首页> 美国卫生研究院文献>Epidemiology and Infection >Infection prevention in patients with cancer: microbiological evaluation of portable laminar air flow isolation topical chlorhexidine and oral non-absorbable antibiotics.
【2h】

Infection prevention in patients with cancer: microbiological evaluation of portable laminar air flow isolation topical chlorhexidine and oral non-absorbable antibiotics.

机译:癌症患者的感染预防:便携式层流气流隔离局部洗必太和口服不可吸收抗生素的微生物学评估。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The increasing use of intensive cytotoxic chemotherapy for patients with solid tumours enhances the risk of opportunistic infection to levels formerly seen only in patients with acute leukaemia, and prevention of infection is a major concern. A relatively simple regimen of isolation, topical antisepsis, and orally administered non-absorbable antibiotics was studied in 18 patients. Sixteen of 21 studies were performed using portable laminar air flow apparatus and five with isolation only. All patients became severely neutropenic but there were no major infections. Microbiological results showed effective decontamination of the skin, which was maintained without recolonization or acquisition of new organisms. The ears, nose and throat were effectively decontaminated only when the regimen was intensified. Colonization with Pseudomonas aeruginosa, a major pathogen in compromised hosts, did not occur. The protective regimen is less expensive than regimens previously described, is acceptable to patients, and requires no modification of existing hospital rooms. It merits further evaluation in patients with common cancers who receive intensive cytotoxic drug therapy.
机译:对于实体瘤患者,强化细胞毒性化学疗法的使用日益增加,使机会性感染的风险增加到以前仅在急性白血病患者中看到的水平,因此,预防感染是一个主要问题。在18位患者中研究了相对简单的隔离,局部防腐和口服非吸收性抗生素治疗方案。 21项研究中有16项是使用便携式层流设备进行的,而5项仅采用隔离进行。所有患者均严重中性粒细胞减少,但无重大感染。微生物学结果表明,可以对皮肤进行有效的净化处理,而无需重新定殖或获得新的生物体即可维持。仅在加强治疗时才对耳朵,鼻子和喉咙进行有效净化。铜绿假单胞菌(受感染宿主中的主要病原体)未发生定植。该保护方案比先前描述的方案便宜,患者可以接受,并且不需要修改现有的病房。在接受密集细胞毒性药物治疗的常见癌症患者中,它值得进一步评估。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号